Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis

Main Article Content

James Q. Del Rosso
Pearl Kwong
Iftikhar Hussain
Sebastien Barbarot
Jose Manuel Carrascosa
Maria Jose Rueda
Amber Reck Atwater
Hany Elmaraghy
Luna Sun
Sherry Chen
Chitra Natalie
Stephan Weidinger


Lebrikizumab, Atopic Dermatitis


1. Tsoi LC et al. J Invest Dermatol. 2019; 139:1480-9.

2. Ultsch M et al. J Mol Biol. 2013; 425:1330-9.

3. Okragly A, et al. Presented at the Inflammatory Skin Disease Summit, New York, 2021

4. Silverberg J et al. Presented at American Academy of Dermatology (AAD), Virtual Meeting Experience, 2022

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 > >>